0.00Open0.04Pre Close0 Volume175 Open Interest74.00Strike Price0.00Turnover111.29%IV4.02%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0371Delta0.0403Gamma1926.38Leverage Ratio-0.3871Theta0.0000Rho-71.39Eff Leverage0.0015Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet